Custom Antibody Growth Leverage ProSci’s strong custom antibody services and RUO biosimilars to target preclinical and early-stage therapeutic research opportunities, offering tailored solutions for unique research challenges and cost-effective oncology diagnostics research.

CRO & Diagnostic Partnerships Target CROs and diagnostic developers to expand collaborative opportunities, aligning ProSci’s end-to-end support, QA/QC rigor, and rapid 2–6 month turnaround with partners requiring scalable supply chains and reliable antibody reagents.

Large Catalog Utilization Promote the vast catalog of over 50,000 products as a one-stop source for researchers, enabling bundled offerings and recurring purchases through project-based needs, peptide design assistance, and custom labeling (HRP/biotin).

Research Trend Alignment Position ProSci as a partner for therapeutics, diagnostics, and basic science tool development aligned with current market trends in antibody discovery, recombinant monoclonals for batch consistency, and flexible immunization strategies.

Growth Through Global Reach Capitalize on ProSci’s global researcher base and 28-year legacy by targeting institutions and labs expanding in oncology and diagnostic research, emphasizing reliable performance, rapid turnaround, and collaborative supply chain simplification.